Hospital factors and patient characteristics in the treatment of colorectal cancer: A population based study

BMC Public Health

Volumn 12, Issue 1, 2012, Pages

  Sacerdote, Carlotta ^a   Baldi, Ileana ^a   Bertetto, Oscar ^b   Dicuonzo, Daniela ^a   Farina, Enzo ^b   Pagano, Eva ^a   Rosato, Rosalba ^a   Senore, Carlo ^b   Merletti, Franco ^a   Ciccone, Giovannino ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

Author keywords

Colorectal cancer; Hospital discharges; In hospital mortality; Quality of care; Radiotherapy

Indexed keywords

AGED; ARTICLE; COHORT ANALYSIS; COLORECTAL TUMOR; FEMALE; HEALTH CARE DISPARITY; HEALTH CARE QUALITY; HOSPITAL; HUMAN; ITALY; MALE; MIDDLE AGED; MORTALITY; RISK FACTOR; SOCIOECONOMICS; STATISTICS; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; COHORT STUDIES; COLORECTAL NEOPLASMS; FEMALE; HEALTHCARE DISPARITIES; HOSPITAL MORTALITY; HOSPITALS; HUMANS; ITALY; MALE; MIDDLE AGED; QUALITY INDICATORS, HEALTH CARE; RISK FACTORS; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 84866039266     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-12-775     Document Type: Article

References (43)

1. Global cancer statistics, 2002. Parkin DM, Bray F, Ferlay J, Pisani P, CA Cancer J Clin 2005 55 2 74 108 10.3322/canjclin.55.2.74 15761078 (Pubitemid 40372904)
2. Colorectal cancer. Cunningham D, Atkin W, Lenz HJ, Lynch HT, Minsky B, Nordlinger B, Starling N, Lancet 2010 375 9719 1030 1047 10.1016/S0140-6736(10) 60353-4 20304247
3. The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation. Hind D, Tappenden P, Tumur I, Eggington S, Sutcliffe P, Ryan A, Health Technol Assess 2008 12 15 ii-ix xi-162 18462574
4. Current neoadjuvant strategies in rectal cancer. Julien LA, Thorson AG, J Surg Oncol 2010 101 4 321 326 10.1002/jso.21480 20187066
5. Adjuvant chemotherapy after resection in elderly Medicare and Medicaid patients with colon cancer. Bradley CJ, Given CW, Dahman B, Fitzgerald TL, Arch Intern Med 2008 168 5 521 529 10.1001/archinternmed.2007.82 18332299 (Pubitemid 351547216)
6. Social inequality and incidence of and survival from cancers of the colon and rectum in a population-based study in Denmark, 1994-2003. Egeberg R, Halkjaer J, Rottmann N, Hansen L, Holten I, Eur J Cancer 2008 44 14 1978 1988 10.1016/j.ejca.2008.06.020 18667301
7. A national perspective on the decline of abdominoperineal resection for rectal cancer. Tilney HS, Heriot AG, Purkayastha S, Antoniou A, Aylin P, Darzi AW, Tekkis PP, Ann Surg 2008 247 1 77 84 10.1097/SLA.0b013e31816076c3 18156926
8. Use of administrative data or clinical databases as predictors of risk of death in hospital: comparison of models. Aylin P, Bottle A, Majeed A, BMJ 2007 334 7602 1044 10.1136/bmj.39168.496366.55 17452389 (Pubitemid 46808454)
9. Accessing and using hospital activity data. Hansell A, Bottle A, Shurlock L, Aylin P, J Public Health Med 2001 23 1 51 56 10.1093/pubmed/23.1.51 11315695 (Pubitemid 32246302)
10. Developing a reliable, valid, and feasible plan for quality-of-care measurement for cancer: how should we measure? Kahn KL, Malin JL, Adams J, Ganz PA, Med Care 2002 40 6 Suppl II73 III85 12064761
11. How accurate are hospital discharge data for evaluating effectiveness of care? Green J, Wintfeld N, Med Care 1993 31 8 719 731 10.1097/00005650- 199308000-00005 8336511
12. Management and survival of patients with adenocarcinoma of the colon and rectum: a national survey of the Commission on Cancer. Beart RW, Steele GD Jr, Menck HR, Chmiel JS, Ocwieja KE, Winchester DP, J Am Coll Surg 1995 181 3 225 236 7670682
13. Racial disparities in rectal cancer treatment: a population-based analysis. Morris AM, Billingsley KG, Baxter NN, Baldwin LM, Arch Surg 2004 139 2 151 155 discussion 156 10.1001/archsurg.139.2.151 14769572 (Pubitemid 38174708)
14. Surgeon-related factors and outcome in rectal cancer. Porter GA, Soskolne CL, Yakimets WW, Newman SC, Ann Surg 1998 227 2 157 167 10.1097/00000658- 199802000-00001 9488510 (Pubitemid 28087906)
15. The surgeon as a prognostic factor after the introduction of total mesorectal excision in the treatment of rectal cancer. Martling A, Cedermark B, Johansson H, Rutqvist LE, Holm T, Br J Surg 2002 89 8 1008 1013 10.1046/j.1365-2168.2002.02151.x 12153626 (Pubitemid 34994693)
16. Tumori del Colon-Retto. Linee guida clinico organizzative per la Regione Piemonte. Regione, Piemonte, Commissione Oncologica Regionale Turin, Italy: Assessorato Sanità 2001
17. Preoperative or postoperative therapy for stage II or III rectal cancer: an updated practice guideline. Wong RK, Berry S, Spithoff K, Simunovic M, Chan K, Agboola O, Dingle B, Clin Oncol (R Coll Radiol) 2010 22 4 265 271 10.1016/j.clon.2010.03.002
18. Sphincter preservation therapy for distal rectal carcinoma: a review. Ng AK, Recht A, Busse PM, Cancer 1997 79 4 671 683 10.1002/(SICI)1097- 0142(19970215)79:4<671::AID-CNCR3>3.0.CO;2-H 9024704 (Pubitemid 27076332)
19. Quality of life in survivors of colorectal carcinoma. Ramsey SD, Andersen MR, Etzioni R, Moinpour C, Peacock S, Potosky A, Urban N, Cancer 2000 88 6 1294 1303 10.1002/(SICI)1097-0142(20000315)88:6<1294::AID-CNCR4>3.0.CO;2-M 10717609 (Pubitemid 30155164)
20. Quality of life after surgery for rectal cancer: do we still need a permanent colostomy? Renner K, Rosen HR, Novi G, Holbling N, Schiessel R, Dis Colon Rectum 1999 42 9 1160 1167 10.1007/BF02238568 10496556 (Pubitemid 29439288)
21. Variations in treatment of rectal cancer: the influence of hospital type and caseload. Simons AJ, Ker R, Groshen S, Gee C, Anthone GJ, Ortega AE, Vukasin P, Ross RK, Beart RW Jr, Dis Colon Rectum 1997 40 6 641 646 10.1007/BF02140891 9194456 (Pubitemid 27255943)
22. Volume-outcome analysis of colorectal cancer-related outcomes. Borowski DW, Bradburn DM, Mills SJ, Bharathan B, Wilson RG, Ratcliffe AA, Kelly SB, Br J Surg 2010 97 9 1416 1430 10.1002/bjs.7111 20632311
23. Volume and outcome in colorectal cancer surgery. van Gijn W, Gooiker GA, Wouters MW, Post PN, Tollenaar RA, van de Velde CJ, Eur J Surg Oncol 2010 36 Suppl 1 55 S63 20615649
24. Iezzoni L, Risk adjustment for measuring health care outcomes Chicago: Health Administration Press 3 2003
25. Social variations in access to hospital care for patients with colorectal, breast, and lung cancer between 1999 and 2006: retrospective analysis of hospital episode statistics. Raine R, Wong W, Scholes S, Ashton C, Obichere A, Ambler G, BMJ 2010 340 5479 10.1136/bmj.b5479 20075152
26. A high positive predictive value algorithm using hospital administrative data identified incident cancer cases. Baldi I, Vicari P, Di Cuonzo D, Zanetti R, Pagano E, Rosato R, Sacerdote C, Segnan N, Merletti F, Ciccone G, J Clin Epidemiol 2008 61 4 373 379 10.1016/j.jclinepi.2007.05.017 18313562 (Pubitemid 351289039)
27. Disease staging classification system. Gonnella JS, Louis DZ, Med Care 1987 25 4 360 10.1097/00005650-198704000-00009 3121948
28. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. Romano PS, Roos LL, Jollis JG, J Clin Epidemiol 1993 46 10 1075 1079 discussion 1081-1090 10.1016/0895-4356(93) 90103-8 8410092 (Pubitemid 23302074)
29. All Patient Refined-Diagnosis-Related Groups (APR-DRGS) Version 20.0: Methodology Overview. Averill R, Goldfield N, Hughes J, Bonazelli J, Mc Cullough E, Steinbeck B, Mullin R, AT, Health Information Systems Wallingford, CT: 3 M Health Information Systems 2003
30. Matrix of distances between Piedmont town. IRES, Collana Banca Dati Turin: Piemonte Servizio di Epidemiologia-ASL 5 2004
31. Cancer rates, medical comorbidities, and treatment modalities in the oldest patients. Zeber JE, Copeland LA, Hosek BJ, Karnad AB, Lawrence VA, Sanchez-Reilly SE, Crit Rev Oncol Hematol 2008 67 3 237 242 10.1016/j. critrevonc.2008.02.002 18356072
32. Half of elderly patients routinely treated for colorectal cancer receive a sub-standard treatment. Aparicio T, Navazesh A, Boutron I, Bouarioua N, Chosidow D, Mion M, Choudat L, Sobhani I, Mentre F, Soule JC, Crit Rev Oncol Hematol 2009 71 3 249 257 10.1016/j.critrevonc.2008.11.006 19131256
33. Residual treatment disparities after oncology referral for rectal cancer. Morris AM, Billingsley KG, Hayanga AJ, Matthews B, Baldwin LM, Birkmeyer JD, J Natl Cancer Inst 2008 100 10 738 744 10.1093/jnci/djn145 18477800
34. Male gender adversely affects survival following surgery for colorectal cancer. McArdle CS, McMillan DC, Hole DJ, Br J Surg 2003 90 6 711 715 10.1002/bjs.4098 12808619 (Pubitemid 36760600)
35. Gender influences treatment and survival in colorectal cancer surgery. Paulson EC, Wirtalla C, Armstrong K, Mahmoud NN, Dis Colon Rectum 2009 52 12 1982 1991 10.1007/DCR.0b013e3181beb42a 19959975
36. Influence of marital status on survival from colon and rectal cancer in Denmark. Johansen C, Schou G, Soll-Johanning H, Mellemgaard A, Lynge E, Br J Cancer 1996 74 6 985 988 10.1038/bjc.1996.470 8826871 (Pubitemid 26319338)
37. Effects of socioeconomic status and treatment disparities in colorectal cancer survival. Le H, Ziogas A, Lipkin SM, Zell JA, Cancer Epidemiol Biomarkers Prev 2008 17 8 1950 1962 10.1158/1055-9965.EPI-07-2774 18708384
38. Access to hospital care, clinical stage and survival from colorectal cancer according to socio-economic status. Ciccone G, Prastaro C, Ivaldi C, Giacometti R, Vineis P, Ann Oncol 2000 11 9 1201 1204 10.1023/A:1008352119907 11061620
39. The effect of provider case volume on cancer mortality: systematic review and meta-analysis. Gruen RL, Pitt V, Green S, Parkhill A, Campbell D, Jolley D, CA Cancer J Clin 2009 59 3 192 211 10.3322/caac.20018 19414631
40. Influence of caseload and surgical speciality on outcome following surgery for colorectal cancer: a review of evidence. Part 2: long-term outcome. Iversen LH, Harling H, Laurberg S, Wille-Jorgensen P, Colorectal Dis 2007 9 1 38 46 10.1111/j.1463-1318.2006.01095.x 17181844 (Pubitemid 44869674)
41. The effect of hospital and surgeon volume on outcomes for rectal cancer surgery. Salz T, Sandler RS, Clin Gastroenterol Hepatol 2008 6 11 1185 1193 10.1016/j.cgh.2008.05.023 18829393
42. Travel time to hospital and treatment for breast, colon, rectum, lung, ovary and prostate cancer. Jones AP, Haynes R, Sauerzapf V, Crawford SM, Zhao H, Forman D, Eur J Cancer 2008 44 7 992 999 10.1016/j.ejca.2008.02.001 18375117
43. The impact of comorbidity on survival of Danish colorectal cancer patients from 1995 to 2006-a population-based cohort study. Iversen LH, Norgaard M, Jacobsen J, Laurberg S, Sorensen HT, Dis Colon Rectum 2009 52 1 71 78 10.1007/DCR.0b013e3181974384 19273959